Aarti Drugs Limited (BOM:524348)
India flag India · Delayed Price · Currency is INR
423.50
+10.90 (2.64%)
At close: Jul 31, 2026

Aarti Drugs Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,9491,6821,7141,6632,050
Depreciation & Amortization
669.7541.94510.48501.28500.08
Other Amortization
-15.833.991.960.41
Loss (Gain) From Sale of Assets
--0.31.83-1.11-0.17
Asset Writedown & Restructuring Costs
-12.32---
Loss (Gain) From Sale of Investments
0.5-2.712.92--
Provision & Write-off of Bad Debts
36.637.2218.967.5916.87
Other Operating Activities
521.6124.08309.02323.7710.09
Change in Accounts Receivable
-700343.51,611-944.22-1,939
Change in Inventory
-178.5129.64342.4658.22-1,106
Change in Accounts Payable
236.3-437.26-925.31-277.371,171
Operating Cash Flow
2,5352,4463,5891,333704.14
Operating Cash Flow Growth
3.66%-31.86%169.22%89.34%-54.56%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-1,733-1,772-2,263-1,648-1,520
Sale of Property, Plant & Equipment
2.80.481.871.450.2
Investment in Securities
-15.32.71---
Other Investing Activities
11.6122.1224.97723.15
Investing Cash Flow
-1,734-1,646-2,237-1,640-1,496

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-409.24-13.972,028
Long-Term Debt Issued
430.3702.41,4821,158-
Total Debt Issued
430.31,1121,4821,1722,028
Short-Term Debt Repaid
-132.3--1,245--
Long-Term Debt Repaid
-567.8-776.08-459.36-558.61-68.69
Total Debt Repaid
-700.1-776.08-1,705-558.61-68.69
Net Debt Issued (Repaid)
-269.8335.56-222.85613.741,959
Issuance of Common Stock
---7.56-
Repurchase of Common Stock
--731.73-731.73--738.38
Common Dividends Paid
-181.7-90.61-92.67-94.01-95.08
Other Financing Activities
-322.9-334.41-313.08-361.86-205.78
Financing Cash Flow
-774.4-821.19-1,360165.42920.25

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
-0---0
Net Cash Flow
26.9-21.65-7.61-141.09127.99

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
802.2674.221,326-314.97-815.61
Free Cash Flow Growth
18.98%-49.15%---
Free Cash Flow Margin
3.13%2.83%5.24%-1.16%-3.28%
Free Cash Flow Per Share
8.797.3914.42-3.40-8.81
Levered Free Cash Flow
-60.06-150.241,028-802.36-1,169
Unlevered Free Cash Flow
150.6373.961,237-594.28-1,040

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
323334.4313.08361.86205.79
Cash Income Tax Paid
-41551.17624596.75833.77
Change in Working Capital
-642.235.881,028-1,163-1,874